These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 31605579)

  • 1. Near final adult height, and body mass index in overweight/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs.
    Sinthuprasith P; Dejkhamron P; Wejaphikul K; Unachak K
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1369-1375. PubMed ID: 31605579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of GnRH agonist treatment on body mass index in girls with idiopathic central precocious puberty.
    Vuralli D; Ozon ZA; Gonc EN; Alikasifoglu A; Kandemir N
    J Pediatr Endocrinol Metab; 2020 Jan; 33(1):99-105. PubMed ID: 31804960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of BMI on long-term anthropometric and metabolic outcomes in girls with idiopathic central precocious puberty treated with GnRHas.
    Bruzzi P; Valeri L; Sandoni M; Madeo SF; Predieri B; Lucaccioni L; Iughetti L
    Front Endocrinol (Lausanne); 2022; 13():1006680. PubMed ID: 36263328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN; Liang L; Cai XD; Li Z; Bai M; Gu CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with gonadotropin-releasing hormone analogues: different impact on body weight in normal-weight and overweight children.
    Wolters B; Lass N; Reinehr T
    Horm Res Paediatr; 2012; 78(5-6):304-11. PubMed ID: 23257624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P; Suphasit R; Mahachoklertwattana P
    Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal assessment of auxological parameters, adult height outcome and its determinants in leuprolide-treated Indian girls with idiopathic central precocious puberty.
    Mondkar S; Khadilkar V; Yewale S; Dange N; More C; Khadilkar A
    J Pediatr Endocrinol Metab; 2024 Jan; 37(1):62-68. PubMed ID: 38008794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final adult height in children with central precocious puberty - a retrospective study.
    Knific T; Lazarevič M; Žibert J; Obolnar N; Aleksovska N; Šuput Omladič J; Battelino T; Avbelj Stefanija M
    Front Endocrinol (Lausanne); 2022; 13():1008474. PubMed ID: 36531464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.
    Li P; Li Y; Yang CL
    Medicine (Baltimore); 2014 Dec; 93(27):e260. PubMed ID: 25501098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of GnRH analog treatment on BMI in children treated for precocious puberty: a systematic review and meta-analysis.
    Zhu X; Qin J; Xue W; Li S; Zhao M; Yingliang Jin
    J Pediatr Endocrinol Metab; 2024 Apr; 37(4):297-308. PubMed ID: 38407229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in body mass index in children on gonadotropin-releasing hormone agonist therapy with precocious puberty, early puberty or short stature.
    Censani M; Feuer A; Orton S; Askin G; Vogiatzi M
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1065-1070. PubMed ID: 31465296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The different effects of gonadotropin-releasing hormone agonist therapy on body mass index and growth between normal-weight and overweight girls with central precocious puberty.
    Yang WJ; Ko KH; Lee KH; Hwang IT; Oh YJ
    Ann Pediatr Endocrinol Metab; 2017 Mar; 22(1):49-54. PubMed ID: 28443259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
    Pucarelli I; Segni M; Ortore M; Moretti A; Iannaccone R; Pasquino AM
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.
    Palmert MR; Mansfield MJ; Crowley WF; Crigler JF; Crawford JD; Boepple PA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4480-8. PubMed ID: 10599706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index evolution and ovarian function in adolescent girls who received GnRH agonist treatment for central precocious puberty or early and fast puberty.
    Buyukyilmaz G; Koca SB; Adiguzel KT; Gurbuz F; Boyraz M
    J Pediatr Endocrinol Metab; 2023 Nov; 36(11):1044-1051. PubMed ID: 37735929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F; Federico G; Harrell JC; Saggese G
    Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty.
    Arcari AJ; Freire AV; Escobar ME; Ballerini MG; Ropelato MG; Bergadá I; Gryngarten MG
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):181-186. PubMed ID: 30699070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty.
    Kim HR; Nam HK; Rhie YJ; Lee KH
    Ann Pediatr Endocrinol Metab; 2017 Dec; 22(4):259-265. PubMed ID: 29301187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Patients with Central Precocious Puberty Due to Loss-of-Function Mutations in the MKRN3 Gene after Treatment with Gonadotropin-Releasing Hormone Analog.
    Ramos CO; Macedo DB; Canton APM; Cunha-Silva M; Antonini SRR; Stecchini MF; Seraphim CE; Rodrigues T; Mendonca BB; Latronico AC; Brito VN
    Neuroendocrinology; 2020; 110(7-8):705-713. PubMed ID: 31671431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.